The Desitin Arzneimittel GmbH is active on a european level (Germany, Switzerland, Scandinavia, Eastern Europe). At our plant situated in Hamburg we produce sophisticated products for the treatment of neurological and psychiatric illnesses and offer a large number of established and innovative products, especially for our core indications epilepsy and Parkinson's syndrome.
The optimisation of pharmacotherapy through continuous improvement of galenic formulations with a focus on central nervous System disorders, alone or in cooperation with other future-oriented companies is one of Desitin's main areas of activity and investment.
